Share Twitter LinkedIn Facebook Email Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses his presentation, Overview of Novel Treatments for HCC in the Era of Hep C Therapies, which was discussed at the 2016 Great Debates and Updates in GI Malignancies in New York, NY
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read